Middle East respiratory syndrome coronavirus – outbreak Reported in Saudi Arabia
On May 12, 2025, the the Ministry of Health (MoH) of the Kingdom of Saudi Arabia (KSA) reported…
WHO reported Increase in Rwanda Marburg virus disease incidence
On Oct. 11, 2024, the World Health Organization (WHO) reported that a total of 58 cases of Marburg…
MERS coronavirus case reported in Saudi Arabia
On Oct. 2, 2024, the World Health Organization (WHO) announced it had been notified of one human case…
WHO launched CoViNet: a global network for coronaviruses
On Mar. 27, 2024, the World Health Organization announced it had launched a network for coronaviruses, CoViNet, to…
Biotechnology | COVID-19 | Disease | WHO
Middle East Respiratory Syndrome reported in United Arab Emirates
On Jul. 24, 2023, the United Arab Emirates (UAE), notified WHO of a case of Middle East Respiratory…
INOVIO dosed first participant in phase 2 trial for its DNA vaccine against MERS, a Coronavirus Disease
On Aug. 4, 2021, Inovio Pharma announced that the company had dosed the first Phase 2 trial subject…
Monoclonal antibodies against MERS Coronavirus showed promise in phase 1 NIH-sponsored trial
On Feb. 23, 2021, the NIH announced that a randomized, placebo-controlled Phase 1 clinical trial of two monoclonal…
Additional COVID-19 related genes ﾖ both helpful and harmful ﾖ revealed in massive screen
On Oct. 27, 2020, researchers at Yale University and the Broad Institute of MIT and Harvard screened hundred…
Disease | NIH | Therapeutics
NIAID awarded BioCryst $44 million contract to advance development of galidesivir
On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…
Cerus reported successful inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma
On Jul. 7, 2020, Cerus announced study results that demonstrated the INTERCEPT Blood System inactivates SARS-CoV-2, the causative…
BioCryst’s galidesivir stops Zika viral replication in primate model
On Jun. 11, 2020, BioCryst Pharmaceuticals announced new data published in Science Translational Medicine that show, in a…
Innovation Pharma collaborated with regional biocontainment lab on grant application to research Brilacidin as pan-Coronavirus therapeutic
On Jun. 11, 2020, Innovation Pharma announced the Company and researchers at a U.S. Regional Biocontainment Laboratory (RBL)…
Llama antibody engineered to block Coronavirus
On May 19, 2020, the National Institutes of Health (NIH) reported that researchers from the University of Texas,…
INOVIO and GeneOne reported positive phase 1/2a clinical data with DNA vaccine INO-4700 for MERS Coronavirus
On Apr. 28, 2020, INOVIO and GeneOne Life Science announced interim data through week 16 from a Phase…
Microneedle coronavirus vaccine triggered immune response in mice
On Apr. 14, 2020, researchers from the University of Pittsburgh announced that they had adapted a system to…
Successful MERS vaccine in mice may hold promise for COVID-19 vaccine
On Apr. 7, 2020, researchers at the University of Iowa and the University of Georgia announced they had…
VBI Vaccines announced collaboration with National Research Council of Canada to develop pan-Coronavirus vaccine candidate
On Mar. 31, 2020, VBI Vaccines announced a collaboration with the National Research Council of Canada (NRC) to…
UC Health launched clinical trials to assess antiviral drug for COVID-19
On Mar. 26, 2020, physician-scientists at four University of California Health medical centers — UC San Diego Health,…
Predictive Oncology launched new AI platform for vaccine and drug development targeting coronaviruses and Acute Respiratory Syndromes
On Mar. 12, 2020, Predictive Oncology announced it will launch a new AI platform for vaccine and drug…
Qatar reported one confirmed case of Middle East Respiratory Syndrome Coronavirus infection
On May 12, 2022, the National IHR Focal Point for Qatar reported two laboratory-confirmed cases of Middle East…
Remdesivir prevented MERS coronavirus disease in monkeys
On Feb. 13, 2020, National Institutes of Health (NIH) scientists announced that the experimental antiviral remdesivir successfully prevented…
New MERS Coronavirus vaccine clinical trial started in Saudi Arabia
On Dec. 20, 2019, Vaccitech’s partner, the University of Oxford’s Jenner Institute, in collaboration with The King Abdullah…
Vaccitech licensed MERS rights to Oxford University
On Sept. 27, 2018, CEPI (the Coalition for Epidemic Preparedness Innovations) announced a collaboration with The Jenner Institute…
The first U.S. imported case of Middle East Respiratory Syndrome (MERS) was confirmed
On May 1, 2014, the first U.S. imported case of Middle East Respiratory Syndrome (MERS) was confirmed in…
CDC | COVID-19 | Diagnostics | Therapeutics
The CDC activated its Emergency Operations Center to investigate a novel coronavirus, MERS-CoV
In 2013, the U.S. Centers for Disease Control and Prevention (CDC) activated its Emergency Operations Center to investigate…
Middle East Respiratory Syndrome (MERS) was first reported in Saudi Arabia
In 2012, Middle East Respiratory Syndrome (MERS), a viral respiratory illness, was first reported in Saudi Arabia in…